Detalhe da pesquisa
1.
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.
Eur J Nucl Med Mol Imaging
; 51(5): 1268-1286, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366197
2.
EANM enabling guide: how to improve the accessibility of clinical dosimetry.
Eur J Nucl Med Mol Imaging
; 50(7): 1861-1868, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086275
3.
Use of ionizing radiation in a Norwegian cohort of children with congenital heart disease: imaging frequency and radiation dose for the Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Pediatrics (HARMONIC) study.
Pediatr Radiol
; 53(12): 2502-2514, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773444
4.
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.
Eur J Nucl Med Mol Imaging
; 49(6): 1778-1809, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284969
5.
Radionuclides for Targeted Therapy: Physical Properties.
Molecules
; 27(17)2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36080198
6.
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma.
Eur J Nucl Med Mol Imaging
; 48(6): 1902-1914, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196921
7.
Left ventricular regional glucose metabolism in combination with septal scar extent identifies CRT responders.
Eur J Nucl Med Mol Imaging
; 48(8): 2437-2446, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416956
8.
Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable.
Acta Oncol
; 60(11): 1481-1488, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425735
9.
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients.
Eur J Nucl Med Mol Imaging
; 45(7): 1233-1241, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470615
10.
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry.
Eur J Nucl Med Mol Imaging
; 50(10): 3157-3158, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382664
11.
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Eur J Nucl Med Mol Imaging
; 50(9): 2595-2604, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129712
12.
Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose.
Acta Radiol
; 59(2): 132-139, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28509566
13.
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
J Vasc Interv Radiol
; 30(12): 2047-2048, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31676203
14.
Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls.
Phys Med
; 117: 103192, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052710
15.
SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE.
J Nucl Med
; 65(5): 753-760, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548350
16.
Implementation of dosimetry for molecular radiotherapy; results from a European survey.
Phys Med
; 117: 103196, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104033
17.
Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions.
J Nucl Med
; 64(7): 1131-1137, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268424
18.
Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE.
Cancers (Basel)
; 15(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831477
19.
Imaging of 212Pb in mice with a clinical SPECT/CT.
EJNMMI Phys
; 10(1): 47, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603123
20.
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update.
Semin Nucl Med
; 53(3): 413-425, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635112